AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - Results of two parallel first-in-human phase I studies

A. Omlin, R. J. Jones, R. Van Der Noll, T. Satoh, M. Niwakawa, S. A. Smith, J. Graham, M. Ong, R. D. Finkelman, J. H.M. Schellens, A. Zivi, M. Crespo, R. Riisnaes, D. Nava-Rodrigues, M. D. Malone, C. Dive, R. Sloane, D. Moore, J. J. Alumkal, A. DymondP. A. Dickinson, M. Ranson, G. Clack, J. De Bono, T. Elliott

    Research output: Contribution to journalArticlepeer-review

    35 Scopus citations

    Fingerprint

    Dive into the research topics of 'AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - Results of two parallel first-in-human phase I studies'. Together they form a unique fingerprint.

    Medicine & Life Sciences